Conference Coverage

End-of-life aggressive cancer care continues despite recommendations


 

AT THE 2016 ASCO ANNUAL MEETING

References

Limitations of the study include a lack of information on the cause of death (whether related to the cancer, the treatment received, or other), and researchers did not review the medical records to investigate the medical reasons for the use of aggressive care near the end of life.

Pages

Recommended Reading

Radiotherapy for prostate cancer linked to higher risk of secondary malignancies
MDedge Internal Medicine
New drug comparable to voriconazole for aspergillosis
MDedge Internal Medicine
New prediction tool forecasts long-term ICU outcomes for very elderly
MDedge Internal Medicine
When toenail onychomycosis can turn deadly
MDedge Internal Medicine
New CDC opioid guideline targets overprescribing for chronic pain
MDedge Internal Medicine
ABMS approves new addiction medicine subspecialty
MDedge Internal Medicine
Premenopausal age linked to lower sexual function after gynecologic cancer surgery
MDedge Internal Medicine
Patients: Intraperitoneal chemotherapy ‘worth it’ for ovarian cancer
MDedge Internal Medicine
Exercise linked to fewer cardiovascular events in nonmetastatic breast cancer patients
MDedge Internal Medicine
A new sort of consultant: Advising doctors, patients on California’s aid-in-dying law
MDedge Internal Medicine